Orthogonal liquid chromatography-mass spectrometry methods for the comprehensive characterization of therapeutic glycoproteins, from released glycans to intact protein level.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Chromatography A

• Publication date

  2017-05-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.chroma.2017.02.072PMID 28372839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sialic Acid Derivatization for the Rapid Subclass- and Sialic Acid Linkage-Specific MALDI-TOF-MS Analysis of IgG Fc-Glycopeptides.

  2017cited by this paper
• ICH Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Processes

  2017cited by this paper
• High-Throughput Analysis of IgG Fc Glycopeptides by LC-MS.

  2017cited by this paper
• High-Throughput Analysis of the Plasma N-Glycome by UHPLC.

  2017cited by this paper
• The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.

  2017cited by this paper
• High-Throughput N-Glycan Analysis with Rapid Magnetic Bead-Based Sample Preparation.

  2017cited by this paper
• High-Throughput Analysis of the IgG N-Glycome by UPLC-FLR.

  2017cited by this paper
• Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies.

  2016cited by this paper
• Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein Biopharmaceuticals.

  2016cited by this paper
• Characterization of cetuximab Fc/2 dimers by off-line CZE-MS.

  2016cited by this paper
• Applying mini-bore HPAEC-MS/MS for the characterization and quantification of Fc N-glycans from heterogeneously glycosylated IgGs.

  2016cited by this paper
• Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation

  2016cited by this paper
• Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis.

  2016cited by this paper
• Quantitation of Site-Specific Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs.

  2016cited by this paper
• Potential of hydrophilic interaction chromatography for the analytical characterization of protein biopharmaceuticals.

  2016cited by this paper
• Fast, robust and high-resolution glycosylation profiling of intact monoclonal IgG antibodies using nanoLC-chip-QTOF.

  2016cited by this paper
• Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis.

  2016cited by this paper
• Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept

  2016cited by this paper
• Prototype sphere-on-sphere silica particles for the separation of large biomolecules.

  2016cited by this paper
• Reversed-phase separation methods for glycan analysis

  2016cited by this paper
• Site-Specific N-Glycosylation Characterization of Windmill Palm Tree Peroxidase Using Novel Tools for Analysis of Plant Glycopeptide Mass Spectrometry Data.

  2016cited by this paper
• Rapid quantitation of monoclonal antibody N-glyco-occupancy and afucosylation using mass spectrometry.

  2016cited by this paper
• Comparison of procainamide and 2-aminobenzamide labeling for profiling and identification of glycans by liquid chromatography with fluorescence detection coupled to electrospray ionization-mass spectrometry.

  2015cited by this paper
• Glycan analysis of therapeutic glycoproteins

  2015cited by this paper
• Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins*

  2015cited by this paper
• Linkage-specific sialic acid derivatization for MALDI-TOF-MS profiling of IgG glycopeptides.

  2015cited by this paper
• Fc glycans of therapeutic antibodies as critical quality attributes

  2015cited by this paper
• In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

  2015cited by this paper
• Mass spectrometry for glycosylation analysis of biopharmaceuticals

  2015cited by this paper
• Comparative analysis of monoclonal antibody N-glycosylation using stable isotope labelling and UPLC-fluorescence-MS.

  2015cited by this paper
• Systematic evaluation of mobile phase additives for the LC-MS characterization of therapeutic proteins.

  2015cited by this paper
• Characterization of cation exchanger stationary phases applied for the separations of therapeutic monoclonal antibodies.

  2015cited by this paper
• Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods

  2015cited by this paper
• Capillary Electrophoresis-Electrospray Ionization-Mass Spectrometry for Quantitative Analysis of Glycans Labeled with Multiplex Carbonyl-Reactive Tandem Mass Tags.

  2015cited by this paper
• Detection and quantitation of low abundance oligosaccharides in recombinant monoclonal antibodies.

  2015cited by this paper
• Evaluation of new superficially porous particles with carbon core and nanodiamond-polymer shell for proteins characterization.

  2015cited by this paper
• Glycoforms of Immunoglobulin G Based Biopharmaceuticals Are Differentially Cleaved by Trypsin Due to the Glycoform Influence on Higher-Order Structure.

  2015cited by this paper
• Evaluation of a new wide-pore superficially porous material with carbon core and nanodiamond-polymer shell for the separation of proteins.

  2015cited by this paper
• Production of α2,6-sialylated IgG1 in CHO cells

  2015cited by this paper
• Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies.

  2015cited by this paper
• A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins.

  2015cited by this paper
• Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety

  2015cited by this paper
• PNGase F-mediated incorporation of (18)O into glycans for relative glycan quantitation.

  2015cited by this paper
• Design and performance evaluation of a microfluidic ion-suppression module for anion-exchange chromatography.

  2014cited by this paper
• Diversity in structure and functions of antibody sialylation in the Fc.

  2014cited by this paper
• Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity

  2014cited by this paper
• Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 1: Separation-based methods

  2014cited by this paper
• N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality.

  2014cited by this paper
• Online two-dimensional porous graphitic carbon/reversed phase liquid chromatography platform applied to shotgun proteomics and glycoproteomics.

  2014cited by this paper
• Relative Quantitation of Glycopeptides Based on Stable Isotope Labeling Using MALDI-TOF MS

  2014cited by this paper
• Absolute Quantitation of Glycosylation Site Occupancy Using Isotopically Labeled Standards and LC-MS

  2014cited by this paper
• High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzer

  2014cited by this paper
• Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry

  2014cited by this paper
• Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.

  2014cited by this paper
• In vitro and in vivo modifications of recombinant and human IgG antibodies

  2014cited by this paper
• Absolute quantitation of immunoglobulin G and its glycoforms using multiple reaction monitoring.

  2013cited by this paper
• High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples.

  2013cited by this paper
• Characterization of therapeutic antibodies and related products.

  2013cited by this paper
• Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry

  2013cited by this paper
• NanoLC Chips MS/MS for the characterization of N-glycopeptides generated from trypsin digestion of a monoclonal antibody.

  2013cited by this paper
• Mass spectrometric analysis of O-linked oligosaccharides from various recombinant expression systems.

  2013cited by this paper
• Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques

  2013cited by this paper
• Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry.

  2013cited by this paper
• Glycan profiling: label-free analysis of glycoproteins.

  2013cited by this paper
• Increasing the Productivity of Glycopeptides Analysis by Using Higher-Energy Collision Dissociation-Accurate Mass-Product-Dependent Electron Transfer Dissociation

  2012cited by this paper
• LC-MS analysis of glycopeptides of recombinant monoclonal antibodies by a rapid digestion procedure.

  2012cited by this paper
• High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns.

  2012cited by this paper
• Detection and Quantitation of Afucosylated N-Linked Oligosaccharides in Recombinant Monoclonal Antibodies Using Enzymatic Digestion and LC-MS

  2012cited by this paper
• Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products

  2012cited by this paper
• Marketing approval of mogamulizumab

  2012cited by this paper
• A non-innovator version of etanercept for treatment of arthritis.

  2011cited by this paper
• Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database

  2011cited by this paper
• The good, the bad, the ugly: Validating the mass spectrometric analysis of modified peptides

  2011cited by this paper
• N-Glycans Modulate the Function of Human Corticosteroid-Binding Globulin*

  2011cited by this paper
• Acceptable changes in quality attributes of glycosylated biopharmaceuticals

  2011cited by this paper
• High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.

  2011cited by this paper
• Investigation of sialylation aberration in N-linked glycopeptides by lectin and tandem labeling (LTL) quantitative proteomics.

  2010cited by this paper
• A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomics

  2010cited by this paper
• Glycosylation of Therapeutic Proteins

  2010cited by this paper
• Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants.

  2010cited by this paper
• Glycan labeling strategies and their use in identification and quantification

  2010cited by this paper
• Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding*

  2010cited by this paper
• Glycoproteomics in Health and Disease

  2010cited by this paper
• Glycoprotein analysis using protein microarrays and mass spectrometry.

  2010cited by this paper
• LC/MS analysis of complex multiglycosylated human alpha(1)-acid glycoprotein as a model for developing identification and quantitation methods for intact glycopeptide analysis.

  2010cited by this paper
• Methods to determine the level of afucosylation in recombinant monoclonal antibodies.

  2010cited by this paper
• Microarrays in glycoproteomics research.

  2009cited by this paper
• Effects of glycosylation on the stability of protein pharmaceuticals.

  2009cited by this paper
• Evaluation of oligosaccharide methods for carbohydrate analysis in a fully human monoclonal antibody and comparison of the results to the monosaccharide composition determination by a novel calculation.

  2009cited by this paper
• Comparison of Methods for Profiling O-Glycosylation

  2009cited by this paper
• Oligosaccharide analysis by graphitized carbon liquid chromatography–mass spectrometry

  2009cited by this paper
• Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

  2008cited by this paper
• Influence of electrosorption, solvent, temperature, and ion polarity on the performance of LC-ESI-MS using graphitic carbon for acidic oligosaccharides.

  2008cited by this paper
• GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans.

  2008cited by this paper
• Glycosylation of Recombinant Antibody Therapeutics

  2008cited by this paper
• The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies.

  2008cited by this paper
• Studying O-linked protein glycosylations in human plasma.

  2008cited by this paper
• The Function of the Human Interferon-β1a Glycan Determined in Vivo

  2008cited by this paper
• Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum.

  2008cited by this paper
• Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry.

  2008cited by this paper

• Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM).

  2025cites this paper
• An Overview of Biosimilars—Development, Quality, Regulatory Issues, and Management in Healthcare

  2024cites this paper
• Hydrophilic interaction liquid chromatography (HILIC) for the analysis of intact proteins and glycoproteins

  2024cites this paper
• A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies

  2024cites this paper
• Erythropoietin N-glycosylation of Therapeutic Formulations Quantified and Characterized: An Interlab Comparability Study of High-Throughput Methods

  2024cites this paper
• Absolute Quantification of Human Serum Albumin Isoforms by Internal Calibration Based on a Top-Down LC-MS Approach.

  2024cites this paper
• Characterization of Monoclonal Antibody N-Glycan Conformations by Novel Hydrophilic Interaction Liquid Chromatography (HILIC) with Trapped Ion Mobility Mass Spectrometry (TIMS) and Fluorescence Detection (FLD)

  2024cites this paper
• “Small is beautiful” – Examining reliable determination of low-abundant therapeutic antibody glycovariants

  2024cites this paper
• Ultraviolet Photodissociation Permits Comprehensive Characterization of O-Glycopeptides Cleaved with O-Glycoprotease IMPa.

  2023cites this paper
• Using Hadamard Transform Multiplexed IR Spectroscopy Together with a Segmented Ion Trap for the Identification of Mobility-Selected Isomers

  2023cites this paper
• 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies

  2023cites this paper
• Interlaboratory Evaluation of a User-Friendly Benchtop Mass Spectrometer for Multiple-Attribute Monitoring Studies of a Monoclonal Antibody

  2023influential citation
• N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterization.

  2022cites this paper
• Comprehensive N-Glycan Mapping using Parallel Reaction Monitoring LC–MS/MS

  2022cites this paper
• Understanding unfolding and refolding of the antibody fragments (Fab). II. Mapping intra and inter-chain disulfide bonds using mass spectrometry

  2022cites this paper
• High sensitivity acidic N-glycan profiling with MS-enhancing derivatization and mixed mode chromatography.

  2022cites this paper
• Identification and semi-relative quantification of intact glycoforms of human chorionic gonadotropin alpha and beta subunits by nano liquid chromatography-Orbitrap mass spectrometry.

  2021cites this paper
• Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate.

  2021cites this paper
• Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2017-2018.

  2021cites this paper
• Lectin and Liquid Chromatography-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

  2021cites this paper
• HPLC- and CE-based methods for the characterization of therapeutic glycoproteins

  2021cites this paper
• Fast Afucosylation Profiling of Glycoengineered Antibody Subunits by Middle-Up Mass Spectrometry.

  2021cites this paper
• Hydrophilic interaction liquid chromatography-mass spectrometry for the characterization of glycoproteins at the glycan, peptide, subunit, and intact level

  2021cites this paper
• A broad-specificity O-glycoprotease that enables improved analysis of glycoproteins and glycopeptides containing intact complex O-glycans

  2021cites this paper
• Glycosylation of Therapeutic Proteins: A Critical Quality Attribute.

  2021cites this paper
• A new approach for identifying positional isomers of glycans cleaved from monoclonal antibodies

  2021cites this paper
• Characterization of Glycosylated Proteins at Subunit Level by HILIC/MS.

  2021cites this paper
• Analysis of Monoclonal Antibody Glycopeptides by Capillary Electrophoresis-Mass Spectrometry Coupling (CE-MS).

  2021cites this paper
• Enhanced protocol for quantitative N-linked glycomics analysis using Individuality Normalization when Labeling with Isotopic Glycan Hydrazide Tags (INLIGHT)™

  2020cites this paper
• Separation methods hyphenated to mass spectrometry for the characterization of the protein glycosylation at the intact level.

  2020cites this paper
• An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresis.

  2020cites this paper
• At-line high throughput site-specific glycan profiling using targeted mass spectrometry

  2020cites this paper
• Mass Spectrometry‐Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization (OptimAbs)

  2020cites this paper
• Emerging biotechnological approaches with respect to tissue regeneration: from improving biomaterial incorporation to comprehensive omics monitoring

  2020cites this paper
• Synthesis of new asparagine-based glycopeptides for future scanning tunneling microscopy investigations

  2020cites this paper
• Cell culture process metabolomics together with multivariate data analysis tools opens new routes for bioprocess development and glycosylation prediction

  2020cites this paper
• A Simple Strategy to Eliminate Hexosylation Bias in the Relative Quantification of N‐Glycosylation in Biopharmaceuticals

  2020cites this paper
• Identification and semi-relative quantification of intact glycoforms by nano-LC–(Orbitrap)MS: application to the α-subunit of human chorionic gonadotropin and follicle-stimulating hormone

  2020cites this paper
• Analyzing glycans cleaved from a biotherapeutic protein using ultrahigh-resolution ion mobility spectrometry together with cryogenic ion spectroscopy.

  2020cites this paper
• Introducing multifactorial peak crossover in analytical and preparative chromatography via computer-assisted modeling.

  2020cites this paper
• Visualization of the tissue distribution of fullerenols in zebrafish (Danio rerio) using imaging mass spectrometry

  2020cites this paper
• Nonconsensus motif directed chemical synthesis of glutamine‐based glycopeptides

  2020cites this paper
• Therapeutic Fc-fusion proteins: Current analytical strategies.

  2020cites this paper
• Eine einfache Strategie zur Korrektur des Fehlers aufgrund von Hexosylierung bei relativer Quantifizierung der N‐Glykosylierungsvarianten von Biopharmazeutika

  2020cites this paper
• LC-MS characterization of antibody-based therapeutics

  2020cites this paper
• Minor N-Glycan Mapping of Monoclonal Antibody Therapeutics Using Middle-Down NMR Spectroscopy.

  2020cites this paper
• Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation

  2019cites this paper
• An auxiliary matrix for routine analysis of small molecules and biological macromolecules using matrix-assisted laser desorption ionization mass spectrometry

  2019cites this paper
• Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies

  2019cites this paper
• [Biosimilar monoclonal antibodies: comparative study of analytical and functional quality].

  2019cites this paper
• [Developability assessment with case studies highlighting the decision taking].

  2019cites this paper
• Mass spectrometry-based qualitative and quantitative N-glycomics: An update of 2017-2018.

  2019cites this paper
• Anticorps monoclonaux biosimilaires

  2019cites this paper
• Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications.

  2019cites this paper
• Glycans in drug discovery

  2019cites this paper
• [Developability assessment].

  2019cites this paper
• Separation of isomeric glycans by ion mobility spectrometry - the impact of fluorescent labelling.

  2019cites this paper
• Monitoring of immunoglobulin N- and O-glycosylation in health and disease

  2019cites this paper
• Glycan analysis for protein therapeutics.

  2019cites this paper
• 1 Monoclonal Antibody N-Glycosylation Profiling using 1 Capillary Electrophoresis – Mass Spectrometry : 2 Assessment and Method Validation . 3

  2019cites this paper
• Monitoring of antibody glycosylation pattern based on microarray MALDI-TOF mass spectrometry.

  2019cites this paper
• Hydrophilic interaction chromatography for the analysis of biopharmaceutical drugs and therapeutic peptides: A review based on the separation characteristics of the hydrophilic interaction chromatography phases.

  2019cites this paper
• Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies

  2019cites this paper
• Validation of Rapi-Fluor method for glycan profiling and application to commercial antibody drugs.

  2019cites this paper
• Glycan analysis by ion mobility-mass spectrometry and gas-phase spectroscopy.

  2018cites this paper
• Monoclonal antibody N-glycosylation profiling using capillary electrophoresis - Mass spectrometry: Assessment and method validation.

  2018cites this paper
• Orthogonal Middle-up Approaches for Characterization of the Glycan Heterogeneity of Etanercept by Hydrophilic Interaction Chromatography Coupled to High-Resolution Mass Spectrometry.

  2018cites this paper
• Analysis of Glycoforms and Amino Acids in Infliximab and a Biosimilar Product Using New Method with LC/TOF-MS.

  2018cites this paper
• Protocols for the analytical characterization of therapeutic monoclonal antibodies. III - Denaturing chromatographic techniques hyphenated to mass spectrometry.

  2018cites this paper
• Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry.

  2018cites this paper
• Analysis of recombinant monoclonal antibodies in hydrophilic interaction chromatography: A generic method development approach

  2017cites this paper
• Protocols for the analytical characterization of therapeutic monoclonal antibodies. II - Enzymatic and chemical sample preparation.

  2017cites this paper
• Charged Bubble Extractive Ionization Mass Spectrometry for Protein Analysis

  2017cites this paper
• Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering

  2017cites this paper
• “Small is beautiful” – the significance of reliable determination of low-abundant therapeutic antibody glycovariants

  year unknowncites this paper